仕掛品、研究開発費、1年内償還予定の新株予約権付社債
- 【期間】
| 年度 | 仕掛品 | 研究開発費 | 1年内償還予定の新株予約権付社債 |
|---|
| 2008/03 | 65.8億 | | - | | 32.2億 | |
| 2009/03 | 61.8億 | -6.2% | - | | - | |
| 2010/03 | 44.5億 | -28% | - | | - | |
| 2011/03 | 42.3億 | -5% | - | | - | |
| 2012/03 | 43.8億 | +3.5% | - | | - | |
| 2013/03 | 41億 | -6.4% | 18.1億 | | - | |
| 2014/03 | 39億 | -4.8% | 17.2億 | -4.5% | - | |
| 2015/03 | 31.5億 | -19.3% | 18.6億 | +7.6% | - | |
| 2016/03 | 24億 | -23.7% | 20.6億 | +11.1% | - | |
| 2017/03 | 24.8億 | +3% | 22億 | +6.9% | - | |
| 2018/03 | 20.5億 | -17.4% | 24.9億 | +12.9% | - | |
| 2019/03 | 21.3億 | +4.1% | 27.4億 | +10% | - | |
| 2020/03 | 17.2億 | -19.4% | 27.3億 | -0.4% | - | |
| 2021/03 | 16.8億 | -1.9% | 24.9億 | -8.5% | - | |
| 2022/03 | 19.8億 | +17.6% | 26.3億 | +5.7% | - | |
| 2023/03 | 49.4億 | +149.1% | 31.1億 | +18% | - | |
| 2024/03 | 57.6億 | +16.8% | - | | - | |
